Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$2.0B
82M shares
52-week range
$11.84 – $24.99
98% from low
Sector
SERVICES-HOSPITALS
Exchange
NYSE
CS
Borrow rate
0.40%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.65B | $1.78B | $1.73B | $1.91B | $1.97B | $1.99B | $2.01B | $1.91B |
| Cost of revenue | $2.66B | $1.28B | $1.28B | $1.40B | $1.50B | $1.57B | $1.56B | $1.44B |
| Gross profit | $989.5M | $503.1M | $449.3M | $513.2M | $467.0M | $421.6M | $454.3M | $471.9M |
| Gross margin | 27.1% | 28.3% | 25.9% | 26.9% | 23.7% | 21.1% | 22.6% | 24.7% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $445.8M | $171.8M | $98.1M | $202.9M | $172.7M | $7.3M | −$68.7M | $231.1M |
| EBITDA | $527.7M | $203.6M | $146.1M | $236.1M | $156.7M | $29.9M | −$28.4M | $274.2M |
| Net income | $268.6M | −$1.50B | −$796.5M | $131.0M | $66.3M | −$60.4M | −$99.1M | $165.4M |
| Net margin | 7.4% | -84.2% | -45.9% | 6.9% | 3.4% | -3.0% | -4.9% | 8.6% |
| EPS (diluted) | 2.93 | -17.94 | -9.55 | 1.52 | 0.79 | -0.73 | -1.19 | 1.94 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.9B | $2.28 | $2.23–$2.33 | 5 |
| 2027 | $2.0B | $2.36 | $2.22–$2.45 | 4 |
| 2028 | $2.1B | $2.29 | $2.07–$2.46 | 3 |
| 2029 | $2.2B | $2.05 | $2.03–$2.08 | 1 |
Forward consensus · source: Financial Modeling Prep
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
www.pediatrix.comNo one on the platform currently holds MD.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,532,300 | $32.8M |
| Bridgewater Associatesas of 2024-09-30 | 32,881 | $381.1K |
| Execution date | Ratio |
|---|---|
| 2013-12-20 | 2-for-1 |
| 2006-04-28 | 2-for-1 |
No one on the platform has traded MD yet.
| $2.2B |
| — |
| AVAHAveanna Healthcare Holdings Inc. | $8.66 | +2.12% | $1.9B | — |
| GRDNGuardian Pharmacy Services, Inc. | $42.31 | +8.82% | $2.7B | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at NaN× earnings vs its 18.8× historical median P/E.
Fair value ≈ $-19.21 · price $24.69 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$MD – MON: Just Briefly Traded Above Its Trigger Price – Continued Gains Especially With Volume Would Be Buyable 9:30 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/mon-6-29-md-just-briefly-traded-above-its-trigger-price-continued-gains-especially-with-volume-would-be-buyable/
View on StockTwits ↗$MD is trending on social media, but be aware: this is a highly volatile, community-driven crypto project on the Solana blockchain, not a traditional financial ticker. Discussions are currently dominated by "Moonshot" listing campaigns and community voting drives. If you are looking for traditional market data, this is not the ticker you want. Manage risk accordingly; this is an extremely high-beta speculative asset.
View on StockTwits ↗Space names RSI check $MD - 52 $VOYG - 38 $BKSY - 34 $LUNR - 33 We’re not officially “oversold” (<30) yet, but the entire complex is clearly compressing toward that zone - momentum fading, sellers getting exhausted, and positioning getting lighter across the board. This is usually where sentiment feels the worst, even if structurally nothing has changed in the longer-term story.
View on StockTwits ↗https://marketbeat.com/a/8648819/ $MD Pediatrix Medical Group Q1 Earnings Call Highlights
View on StockTwits ↗$MD Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.36 up 44.00% YoY • Reported revenue of $476.2M up 3.89% YoY • Pediatrix reaffirms its full year 2026 outlook for Adjusted EBITDA, anticipating Adjusted EBITDA will be in a range of $280M to $300M.
View on StockTwits ↗$MD reports before the open tomorrow, Estimize Consensus +0.02 EPS and +2.98M Revs compared to WS http://www.estimize.com/md/fq1-2026?utm_c
View on StockTwits ↗$MRDN multi day runner $GME $MD $HUBC $CHSN
View on StockTwits ↗$MD Share Price: $22.83 Contract Selected: Nov 20, 2026 $25 Calls Buy Zone: $0.96 – $1.18 Target Zone: $1.77 – $2.16 Potential Upside: 74% ROI Time to Expiration: 211 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗Why investors keep holding $MD — and the bull case isn’t fading. A favorable payer mix, higher neonatology acuity and prudent acquisitions are supporting growth, while the shares appear undervalued compared with industry peers. 📈 See what’s supporting the investment case 👉 https://www.zacks.com/stock/news/2883225/heres-why-investors-continue-to-hold-pediatrix-medical-stock?cid=sm-stocktwits-2-2883225-teaser-37249&ADID=SYND_STOCKTWITS_TWEET_2_2883225_TEASER_37249
View on StockTwits ↗$MD poised for growth with strong payer mix & patient acuity driving performance! 📈 🔹 Zacks Rank #3 with promising 6.9% EPS growth for 2026 🔹 Undervalued at 9.39x forward P/E vs. industry average of 15.07x Discover why this stock is worth holding 👉 https://www.zacks.com/stock/news/2883225/heres-why-investors-continue-to-hold-pediatrix-medical-stock?cid=sm-stocktwits-2-2883225-body-37248&ADID=SYND_STOCKTWITS_TWEET_2_2883225_BODY_37248
View on StockTwits ↗$MD earnings miss — but is the headline hiding the real story? ⚠️ Q4 EPS missed estimates and revenues dipped, yet same-unit gains and a stronger 2026 EBITDA outlook point to improving underlying momentum. That’s a mixed setup investors shouldn’t ignore. Is this a turnaround brewing or more choppiness ahead? Get the full breakdown 👉 https://www.zacks.com/stock/news/2872924/pediatrix-medical-q4-earnings-miss-estimates-despite-declining-costs?cid=sm-stocktwits-2-2872924-teaser-34422&ADID=SYND_STOCKTWITS_TWEET_2_2872924_TEASER_34422
View on StockTwits ↗$MD misses EPS but beats revenue estimates — what's the full story? 🤔 Pediatrix Medical's Q4 2025 EPS of 50 cents missed the Zacks Consensus Estimate by 4.9%, while revenues of $493.8M beat projections by 0.5%. Despite higher variable practice incentive compensation and lower same-unit revenues, favorable collection activity, payor mix, improved patient acuity and lower operating expenses provided some support. Full breakdown here 👉 https://www.zacks.com/stock/news/2872924/pediatrix-medical-q4-earnings-miss-estimates-despite-declining-costs?cid=sm-stocktwits-2-2872924-body-34421&ADID=SYND_STOCKTWITS_TWEET_2_2872924_BODY_34421
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.